E2F2 and Miyoshi myopathy: When comparing MM patients with subjects without any asbestos-related disease, carriers of two polymorphic E2F2 rs2075995 alleles were less likely to develop MM (OR = 0.35, 95% CI = 0.16–0.78, P = 0.010), even after adjustment for age (OR = 0.35, 95% CI = 0.14–0.84, P = 0.019).